EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹16 Cr | ₹-3.10 Cr | ₹-2.64 Cr | ₹2.07 Cr | ₹-2.05 Cr |
What is the latest Cash Flow from Financing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹-3.10 Cr |
| Mar2023 | ₹-2.64 Cr |
| Mar2022 | ₹2.07 Cr |
| Mar2021 | ₹-2.05 Cr |
How is Cash Flow from Financing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | Positive | |
| Mar2024 | ₹-3.10 Cr | Negative | |
| Mar2023 | ₹-2.64 Cr | Negative | |
| Mar2022 | ₹2.07 Cr | Positive | |
| Mar2021 | ₹-2.05 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹389.8 Cr | -2.5% | -17.5% | 56.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -2.5% |
-17.5% |
56.1% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses